Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6568101 | 0.90 | TSHR (0.51) | ALDH1A1TSHRTHRBPOLBAPEX1 | |
| SCHEMBL41031 | 0.88 | TSHR (0.36) | TSHRTHRB | |
| Acetic Acid SCHEMBL8433810 | 0.86 | TSHR (0.37) | TSHRTHRB | |
| Hydrochloric Acid SCHEMBL2533776 | 0.86 | TSHR (0.35) | TSHRTHRB | |
| Ammonia Solution, Strong SCHEMBL3663515 | 0.86 | TSHR (0.35) | TSHRTHRB | |
| SCHEMBL11101921 | 0.86 | ALDH1A1 (0.60) | ALDH1A1TSHRTHRBPOLBAPEX1 | |
| SCHEMBL10757690 | 0.86 | THRB (0.49) | ALDH1A1TSHRTHRBPOLBAPEX1 | |
| Chloromethane SCHEMBL543091 | 0.84 | TSHR (0.34) | TSHRTHRB | |
| Sulfuric Acid SCHEMBL5068577 | 0.81 | TSHR (0.32) | TSHRTHRB | |
| SCHEMBL7527694 | 0.81 | TSHR (0.67) | ALDH1A1TSHRTHRBPOLBAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8187580-B2 | Polymeric assisted delivery using separate addition | THE PROCTER & GAMBLE COMPANY (US) | 2012-05-29 | — | — | US | disclosed |
| US-7795201-B2 | Personal care compositions | DOW GLOBAL TECHNOLOGIES | 2010-09-14 | — | — | US | disclosed |
| US-7642329-B2 | Acrylate or methacrylate ester of low molecular weight oligomeric lactide copolymerized with vinyl pyridine; for dissolving drugs in solution | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2010-01-05 | — | — | US | disclosed |
| EP-1562542-B1 | PERFUME POLYMERIC PARTICLES | PROCTER & GAMBLE (US) | 2009-10-14 | — | — | EP | disclosed |
| US-20080206168-A1 | Personal Care Compositions | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION | 2008-08-28 | — | — | US | disclosed |
| US-7316994-B2 | Perfume polymeric particles | THE PROCTER & GAMBLE COMPANY (US) | 2008-01-08 | — | — | US | disclosed |
| EP-1838280-A2 | PERSONAL CARE COMPOSITIONS | Dow Global Technologies Inc. (US) | 2007-10-03 | — | — | EP | disclosed |
| US-20070072996-A1 | Oligomeric lactide macromer based copolymer and a process for the preparation thereof | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2007-03-29 | — | — | US | disclosed |
| WO-2006076065-A2 | PERSONAL CARE COMPOSITIONS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2006-07-20 | — | — | WO | disclosed |
| EP-1562542-A1 | PERFUME POLYMERIC PARTICLES | THE PROCTER & GAMBLE COMPANY (US) | 2005-08-17 | — | — | EP | disclosed |
| US-20040110648-A1 | Perfume polymeric particles | PROCTER & GAMBLE COMPANY, THE | 2004-06-10 | — | — | US | disclosed |
| WO-2004041232-A1 | PERFUME POLYMERIC PARTICLES | THE PROCTER & GAMBLE COMPANY (US) | 2004-05-21 | — | — | WO | disclosed |
| US-20040087476-A1 | Utilizing cationic copolymer aftertreatment for longer lasting benefit | PROCTER & GAMBLE COMPANY, THE | 2004-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040087476-A1 | Utilizing cationic copolymer aftertreatment for longer lasting benefit | VEGFA, NACA, POLR1C | ALDH1A1 2765/4885TSHR 2195/4885THRB 3311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.